Earnings

Enovix Shares Slide Despite Q1 Beat as Smartphone Battery Tests Remain Incomplete

Enovix shares dropped 12.9% in after-hours trading Wednesday despite beating Q1 revenue and adjusted-loss estimates, as smartphone battery qualification remains unfinished.

James Calloway · · · 3 min read · 2 views
Enovix Shares Slide Despite Q1 Beat as Smartphone Battery Tests Remain Incomplete
Mentioned in this article
ENVX $7.29 +4.59%

Enovix Corporation (ENVX) saw its shares tumble 12.9% to $6.35 in after-hours trading on Wednesday, even after the company reported first-quarter results that exceeded analyst expectations. The decline came as investors focused on the lack of a definitive timeline for completing smartphone battery qualification, a critical milestone for the silicon-anode battery maker.

Q1 Results Beat Estimates

The Fremont, California-based company reported first-quarter revenue of $7.6 million, a 49% increase year-over-year, surpassing both its internal forecast and the Wall Street consensus of $6.95 million. Enovix also posted an adjusted loss of $0.14 per share, narrower than the $0.16 loss analysts had anticipated, according to data from Investing.com. The results were boosted by defense orders, industrial demand, and smart-eyewear shipments.

Smartphone Qualification Progress

Despite the revenue beat, investor sentiment soured on news that the company's smartphone battery qualification process remains incomplete. Enovix has now passed 72 out of 75 customer specifications, up from 70 in the previous quarter. However, two cycle-life tests and a subzero power test still need to be cleared. Chairman T.J. Rodgers noted in a statement that the company regularly achieves 500-cycle life but remains short of the 800-cycle mark demanded by smartphone customers.

Chief Executive Raj Talluri acknowledged during the earnings call that the qualification process "has taken longer than we originally anticipated," a remark that weighed heavily on the stock. The company has reached an agreement with its lead smartphone customer to use a silicon-specific testing setup, which Enovix argues better reflects real-world usage compared to older standards designed for graphite cells.

Diversification into Other Markets

Enovix is also making strides beyond smartphones. The company has begun early commercial production of a silicon-anode battery tailored for smart eyewear, targeting approximately 50,000 units in 2026. Additionally, its latest investor presentation highlighted a global pipeline of roughly $130 million for products manufactured in Korea, with the majority tied to drone applications. Notably, its MX1-B01 drone cell achieves an energy density of 360 watt-hours per kilogram.

Financial Health and Cash Burn

The company ended the quarter with $582.7 million in cash, cash equivalents, and marketable securities. However, operating cash burn totaled $33.1 million, and free cash flow was negative at $36.3 million. For the second quarter, Enovix expects revenue between $8 million and $9 million, with a non-GAAP per-share loss ranging from $0.13 to $0.17.

Competitive Landscape and Analyst Concerns

Enovix faces mounting competition in the high-performance battery space. Rival Amprius Technologies recently partnered with Intralink to enter South Korea's drone and robotics market, underscoring the intense rivalry where battery weight, flight duration, and payload are critical. Last week, JPMorgan analyst Bill Peterson downgraded Enovix to Underweight, citing concerns over smartphone market pressures and delays in commercialization. Even with progress on qualification, Peterson expects volume ramp to slip further.

While defense, drone, and eyewear sales provide some revenue support, the market's primary focus remains on Enovix's ability to complete smartphone battery qualification, secure production-scale orders, and deliver on its long-term growth narrative.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →